Millennium reports 3.7% stake in MacroGenics
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MacroGenics, Inc. received an amended Schedule 13G indicating that Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander collectively report beneficial ownership of 2,374,296 shares of MacroGenics common stock. This represents 3.7% of the outstanding common stock.
The reporting persons disclose no sole voting or dispositive power and shared voting and shared dispositive power over 2,374,296 shares. They state that the securities are held by entities subject to their voting control or investment discretion and note that the filing should not itself be construed as an admission of beneficial ownership. They also confirm that they now own 5% or less of this class of securities.
Key Figures
Key Terms
beneficially owned financial
dispositive power financial
Joint Filing Agreement regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in MacroGenics (MGNX) does Millennium Management report in this Schedule 13G/A?
Does the Millennium group still hold more than 5% of MacroGenics (MGNX) common stock?
Who are the reporting persons in this MacroGenics (MGNX) Schedule 13G/A amendment?
What disclaimer about beneficial ownership do the MacroGenics (MGNX) reporting persons include?
AI-generated analysis. How Rhea-AI works. Not financial advice.